Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples

Journal of Immunological Methods

Volumn 381, Issue 1-2, 2012, Pages 14-22

  Kotsakis, Athanasios ^a,b   Harasymczuk, Malgorzata ^a   Schilling, Bastian ^a   Georgoulias, Vasilis ^b   Argiris, Athanassios ^a   Whiteside, Theresa L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Cell cryopreservation; Flow cytometry; MDSC subsets; Myeloid derived suppressor cells (MDSC)

Indexed keywords

ARGINASE 1; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; CELL MARKER; HLA DR ANTIGEN; REACTIVE OXYGEN METABOLITE;

ANTIBODY LABELING; ARTICLE; BLOOD SAMPLING; CANCER CELL; CD4+ T LYMPHOCYTE; CELL ASSAY; CELL CRYOPRESERVATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MYELOID DERIVED SUPPRESSOR CELL; MYELOID PROGENITOR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL;

ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, CD15; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARGINASE; CRYOPRESERVATION; FLOW CYTOMETRY; GRANULOCYTES; HLA-DR ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; MONOCYTES; MYELOID CELLS; NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 84861572331     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.04.004     Document Type: Article

References (31)

1. Almand B., Clark J.I., Nikitina E., van Baynen J., English N.R., Knight S.C., Carbone D.P., Gabrilovich D.I. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 2001, 166:678.
2. Bronte V., Apolloni E., Cabrelle A., Ronca R., Serafini P., Zamboni P., Restifo N.P., Zanovello P. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 2000, 96:3838.
3. Bronte V., Wang M., Overwijk W.W., Surman D.R., Pericle F., Rosenberg S.A., Restifo N.P. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J. Immunol. 1998, 161:5313.
4. Chang C.I., Liao J.C., Kuo L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res. 2001, 61:1100.
5. Corzo C.A., Cotter M.J., Cheng P., Cheng F., Kusmartsev S., Sotomayor E., Padhya T., et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 2009, 182:5693.
6. Costantini A., Mancini S., Giuliodoro S., Butini L., Regnery C.M., Silvestri G., Montroni M. Effects of cryopreservation on lymphocyte immunophenotype and function. J. Immunol. Methods 2003, 278:145.
7. Daud A.I., Mirza N., Lenox B., Andrews S., Urbas P., Gao G.X., Lee J.H., Sondak V.K., et al. Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. J. Clin. Oncol. 2008, 26:3235.
8. Diaz-Montero C.M., Salem M.L., Nishimura M.I., Garrett-Mayer E., Cole D.J., Montero A.J. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 2009, 58:49.
9. Elkord E. Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation. J. Immunol. Methods 2009, 347:87.
10. Filipazzi P., Valenti R., Huber V., Pilla L., Canese P., Iero M., Castelli C., Mariani L., Parmiani G., Rivoltini L. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 2007, 25:2546.
11. Gabitass R.F., Annels N.E., Stocken D.D., Pandha H.A., Middleton G.W. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol. Immunother. 2011, 60:1419.
12. Greten T.F., Manns M.P., Korangy F. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 2011, 11:802.
13. Hoechst B., Ormandy L.A., Ballmaier M., Lehner F., Kruger C., Manns M.P., Greten T.F., Korangy F. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008, 135:234.
14. Johansson C.C., Mougiakakos D., Trocme E., All-Ericsson C., Economou M.A., Larsson O., Seregard S., Kiessling R. Expression and prognostic significance of iNOS in uveal melanoma. Int. J. Cancer 2010, 126:2682.
15. Kusmartsev S., Nefedova Y., Yoder D., Gabrilovich D.I. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 2004, 172:989.
16. Kusmartsev S., Su Z., Heiser A., Dannull J., Eruslanov E., Kubler H., Yancey D., Dahm P., Vieweg J. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin. Cancer Res. 2008, 14:8270.
17. Liu C.Y., Wang Y.M., Wang C.L., Feng P.H., Ko H.W., Liu Y.H., Wu Y.C., et al. Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J. Cancer Res. Clin. Oncol. 2010, 136:35.
18. Mandapathil M., Lang S., Gorelik E., Whiteside T.L. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J. Immunol. Methods 2009, 346:55.
19. Mirza N., Fishman M., Fricke I., Dunn M., Neugh A.M., Frost T.J., Lush R.M., Gabrilovich D.I. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 2006, 66:9299.
20. Nagaraj S., Gabrilovich D.I. Myeloid-derived suppressor cells in human cancer. Cancer 2010, 16:348.
21. Nefedova Y., Huang M., Kusmartsev S., Bhattacharya R., Cheng P., Salup R., Jove R., Gabrilovich D. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J. Immunol. 2004, 172:464.
22. Ostrand-Rosenberg S. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol. Immunother. 2010, 59:1593.
23. Poschke I., Mougiakakos D., Hansson J., Masucci G.V., Kiessling R. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 2010, 70:4335.
24. Serafini P., Borrello I., Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 2006, 16:53.
25. Singh R., Pervin S., Karimi A., Cederbaum S., Chaudhuri G. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-l-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res. 2000, 60:3305.
26. Suer Gokmen S., Yoruk Y., Cakir E., Yorulmaz F., Gulen S. Arginase and ornithine, as markers in human non-small cell lung carcinoma. Cancer Biochem. Biophys. 1999, 17:125.
27. Tadmor T., Attias D., Polliack A. Myeloid-derived suppressor cells - their role in haemato-oncological malignancies and other cancers and possible implications for therapy. Br. J. Haematol. 2011, 153:557.
28. Youn J.I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008, 181:5791.
29. van Cruijsen H., van der Veldt A.A., Vroling L., Oosterhoff D., Boxterman H.S., Scheper R.J., Giaccone G., Haanen J.B., et al. Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival. Clin. Cancer Res. 2008, 14:5884.
30. Vuk-Pavlovic S., Bulur P.A., Lin Y., Qin R., Szumlanski C.L., Zhao X., Dietz A.B. Immunosuppressive CD14+HLA-DRlow/-monocytes in prostate cancer. Prostate 2010, 70:443.
31. Zea A.H., Rodriguez P.C., Atkins M.B., Hernandez C., Signoretti S., Zabaleta S., McDermott D., et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005, 65:3044.